Hims (HIMS): FY25 Q1 earnings call, May 5, 2025
No Kalshi or Polymarket word markets were listed for Hims’s May 5, 2025 earnings call (FY25 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
6 matches for “Wegovy”; 5 quoted, at least 25 words apart.
…through our new collaboration with Novo Nordisk, we're expanding access to branded Wegovy to bring subscribers on our platform an even broader range of choice.…
…either branded options, branded tirzepatide or you know Zepbound and Mounjaro, branded Wegovy now, as well as the generic options such as liraglutide injections, or…
…because you were getting about two-thirds of the weight loss as branded Wegovy for one-third of the cost. And so when we think about even…
…think the tailwinds will be things such as the branded partnerships from Wegovy as well as more and more users, continuing to adopt the premium…
…natural tension between the dispensing of the personalized product and the commercial Wegovy that you guys are selling. So was there any, like interaction or…
Agents: this page as TSV at /api/v1/appearances/hims:2025-05-05:earnings_call · words: /api/v1/brief?appearance=hims:2025-05-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP